Options bulls are blasting Hims & Hers Health Inc (NYSE:HIMS) stock today, with 33,000 calls exchanged so far -- 8 times the intraday average volume -- compared to 11,000 puts. While the most popular contract is the January 2025 15-strike call, new positions are being opened at the weekly 5/10 13-strike call as well. This frenzy comes after the telehealth company's top-and bottom-line beat for the first quarter, which has shares up 5.9% to trade at $12.34 at last check.
This preference for bullish bets is new. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 10-day put/call volume ratio sits higher than 94% of readings from the last 12 months, indicating puts have been more popular than usual in the last couple of weeks.
The security also attracted four price-target hikes thanks to a raised full-year forecast, with Guggenheim adjusting to $20 from $17. Additional tailwinds could still come in the form of upgrades, as six of 14 analysts in question carry a tepid "hold" rating on HIMS.
Despite surging above the 40-day moving average right out of the gate, the security is now eyeing a close below this trendline, which emerged as resistance in early April. The $12 region is also enacting pressure. Nevertheless, HIMS amassed a 77.9% lead in the last six months.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
